English
简体中文
Total: £ 56.28
Published Date: 2026-04-20 | Pages: 130 | Tables: 136 | Medical Devices & Consumables
The global Interventional Pulmonology Device market was valued at US$ 2212 million in 2025 and is anticipated to reach US$ 3658 million by 2032, at a CAGR of 7.6% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Interventional Pulmonology Device competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Interventional pulmonology devices are advanced medical instruments designed for the diagnosis and treatment of respiratory system diseases, integrating imaging, bronchoscopy, catheters, and minimally invasive surgical technologies for precise operations within the lungs, airways, and thoracic cavity. These devices are applied in bronchoscopic interventions, airway stent placement, lung tumor ablation, and fluid drainage, aiming to improve diagnostic and therapeutic efficiency, reduce patient trauma, and shorten hospitalization time. With rising incidence of respiratory conditions such as lung cancer, chronic obstructive pulmonary disease (COPD), and bronchiectasis, the application of interventional pulmonology devices in clinical and research settings is expanding, promoting the development of minimally invasive pulmonary care.In 2024, global Interventional pulmonology devices production reached approximately 25.27 m units, with an average global market price of around US$ 81.4 perunit.The average gross profit margin of this product is 55%.
The interventional pulmonology device market is benefiting from the increasing prevalence of respiratory diseases and the growing demand for chronic disease management globally. Trends toward minimally invasive therapies, advancements in precision medicine, and progress in digital imaging technologies provide new growth opportunities. Additionally, population aging and the rising demand for early lung cancer screening drive clinical adoption and R&D investment. Continuous demand from healthcare institutions for efficient and low-trauma treatment solutions further reinforces market growth momentum.The industry faces challenges such as high R&D costs, technological complexity, and the need for specialized operator training. Stringent regulatory requirements and approval processes may delay the launch of new products. High device costs and limited insurance coverage may constrain rapid market penetration. Rapid technological advancements also require continuous R&D investment to maintain competitiveness.
Hospitals and specialized pulmonary centers continue to demand minimally invasive and precise lung diagnostic and therapeutic solutions. Patient preference for fast recovery and low-risk treatments drives the adoption of interventional pulmonology devices. Additionally, increased lung cancer screening, chronic respiratory disease management, and widespread use of bronchoscopies contribute to stable downstream market growth. The development of remote monitoring and digital management technologies also provides new support for clinical use.
Key upstream raw materials for interventional pulmonology devices include high-strength medical-grade stainless steel, nitinol alloys, and high-performance polymers used for catheters, stents, and device casings. High-precision optical lenses, miniature camera sensors, and electronic control components are critical for imaging and navigation systems. Semiconductor and micro-motor materials are used to drive minimally invasive instruments, enabling precise operations. The quality and supply stability of upstream materials directly affect device performance and clinical reliability.
This report delivers a comprehensive overview of the global Interventional Pulmonology Device market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Interventional Pulmonology Device. The Interventional Pulmonology Device market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Interventional Pulmonology Device market comprehensively. Regional market sizes by Type, by Application, by Surgical Type, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Interventional Pulmonology Device manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Boston Scientific
Olympus
Medtronic
Ambu A/S
Pentax (HOYA)
Micro Tech
Fujifilm
CONMED
Teleflex Medical
ICU Medical
Medi-Globe
Merit Medical Systems
TRACOE medical
Karl Storz
Verathon
Well Lead
TuoRen
Segment by Type
Bronchoscope
Pleuroscopy
Respiratory Endotherapy Devices
IP Therapeutic Device
Tracheostomy Tube
Segment by Surgical Type
Minimally Invasive Procedures
Surgical Therapy
Other
Segment by Patient Type
Adult Patients
Geriatric Patients
Pediatric Patients
by Application
Hospital and Clinic
Ambulatory Surgical Centers
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Surgical Type, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Interventional Pulmonology Device manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Interventional Pulmonology Device sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Interventional Pulmonology Device Market Overview
1.1 Product Definition
1.2 Interventional Pulmonology Device by Type
1.2.1 Global Interventional Pulmonology Device Market Value by Type: 2025 vs 2032
1.2.2 Bronchoscope
1.2.3 Pleuroscopy
1.2.4 Respiratory Endotherapy Devices
1.2.5 IP Therapeutic Device
1.2.6 Tracheostomy Tube
1.3 Interventional Pulmonology Device by Surgical Type
1.3.1 Global Interventional Pulmonology Device Market Value by Surgical Type: 2025 vs 2032
1.3.2 Minimally Invasive Procedures
1.3.3 Surgical Therapy
1.3.4 Other
1.4 Interventional Pulmonology Device by Patient Type
1.4.1 Global Interventional Pulmonology Device Market Value by Patient Type: 2025 vs 2032
1.4.2 Adult Patients
1.4.3 Geriatric Patients
1.4.4 Pediatric Patients
1.5 Interventional Pulmonology Device by Application
1.5.1 Global Interventional Pulmonology Device Market Value by Application: 2025 vs 2032
1.5.2 Hospital and Clinic
1.5.3 Ambulatory Surgical Centers
1.6 Global Interventional Pulmonology Device Market Size Estimates and Forecasts
1.6.1 Global Interventional Pulmonology Device Revenue 2021–2032
1.6.2 Global Interventional Pulmonology Device Sales 2021–2032
1.6.3 Global Interventional Pulmonology Device Market Average Price (2021–2032)
1.7 Assumptions and Limitations
2 Interventional Pulmonology Device Market Competition by Manufacturers
2.1 Global Interventional Pulmonology Device Sales Market Share by Manufacturers (2021–2026)
2.2 Global Interventional Pulmonology Device Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Interventional Pulmonology Device Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Interventional Pulmonology Device, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Interventional Pulmonology Device, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Interventional Pulmonology Device, Product Types and Applications
2.7 Global Key Manufacturers of Interventional Pulmonology Device, Date of Entry into the Industry
2.8 Global Interventional Pulmonology Device Market Competitive Situation and Trends
2.8.1 Global Interventional Pulmonology Device Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Interventional Pulmonology Device Players Market Share by Revenue
2.8.3 Global Interventional Pulmonology Device Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Interventional Pulmonology Device Market Scenario by Region
3.1 Global Interventional Pulmonology Device Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Interventional Pulmonology Device Sales by Region: 2021–2032
3.2.1 Global Interventional Pulmonology Device Sales by Region: 2021–2026
3.2.2 Global Interventional Pulmonology Device Sales by Region: 2027–2032
3.3 Global Interventional Pulmonology Device Revenue by Region: 2021–2032
3.3.1 Global Interventional Pulmonology Device Revenue by Region: 2021–2026
3.3.2 Global Interventional Pulmonology Device Revenue by Region: 2027–2032
3.4 North America Interventional Pulmonology Device Market Facts & Figures by Country
3.4.1 North America Interventional Pulmonology Device Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Interventional Pulmonology Device Sales by Country (2021–2032)
3.4.3 North America Interventional Pulmonology Device Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Interventional Pulmonology Device Market Facts & Figures by Country
3.5.1 Europe Interventional Pulmonology Device Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Interventional Pulmonology Device Sales by Country (2021–2032)
3.5.3 Europe Interventional Pulmonology Device Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Interventional Pulmonology Device Market Facts & Figures by Region
3.6.1 Asia Pacific Interventional Pulmonology Device Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Interventional Pulmonology Device Sales by Region (2021–2032)
3.6.3 Asia Pacific Interventional Pulmonology Device Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Interventional Pulmonology Device Market Facts & Figures by Country
3.7.1 Latin America Interventional Pulmonology Device Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Interventional Pulmonology Device Sales by Country (2021–2032)
3.7.3 Latin America Interventional Pulmonology Device Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Interventional Pulmonology Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Interventional Pulmonology Device Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Interventional Pulmonology Device Sales by Country (2021–2032)
3.8.3 Middle East and Africa Interventional Pulmonology Device Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Interventional Pulmonology Device Sales by Type (2021–2032)
4.1.1 Global Interventional Pulmonology Device Sales by Type (2021–2026)
4.1.2 Global Interventional Pulmonology Device Sales by Type (2027–2032)
4.1.3 Global Interventional Pulmonology Device Sales Market Share by Type (2021–2032)
4.2 Global Interventional Pulmonology Device Revenue by Type (2021–2032)
4.2.1 Global Interventional Pulmonology Device Revenue by Type (2021–2026)
4.2.2 Global Interventional Pulmonology Device Revenue by Type (2027–2032)
4.2.3 Global Interventional Pulmonology Device Revenue Market Share by Type (2021–2032)
4.3 Global Interventional Pulmonology Device Price by Type (2021–2032)
5 Segment by Application
5.1 Global Interventional Pulmonology Device Sales by Application (2021–2032)
5.1.1 Global Interventional Pulmonology Device Sales by Application (2021–2026)
5.1.2 Global Interventional Pulmonology Device Sales by Application (2027–2032)
5.1.3 Global Interventional Pulmonology Device Sales Market Share by Application (2021–2032)
5.2 Global Interventional Pulmonology Device Revenue by Application (2021–2032)
5.2.1 Global Interventional Pulmonology Device Revenue by Application (2021–2026)
5.2.2 Global Interventional Pulmonology Device Revenue by Application (2027–2032)
5.2.3 Global Interventional Pulmonology Device Revenue Market Share by Application (2021–2032)
5.3 Global Interventional Pulmonology Device Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Boston Scientific
6.1.1 Boston Scientific Company Information
6.1.2 Boston Scientific Description and Business Overview
6.1.3 Boston Scientific Interventional Pulmonology Device Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Boston Scientific Interventional Pulmonology Device Product Portfolio
6.1.5 Boston Scientific Recent Developments/Updates
6.2 Olympus
6.2.1 Olympus Company Information
6.2.2 Olympus Description and Business Overview
6.2.3 Olympus Interventional Pulmonology Device Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Olympus Interventional Pulmonology Device Product Portfolio
6.2.5 Olympus Recent Developments/Updates
6.3 Medtronic
6.3.1 Medtronic Company Information
6.3.2 Medtronic Description and Business Overview
6.3.3 Medtronic Interventional Pulmonology Device Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Medtronic Interventional Pulmonology Device Product Portfolio
6.3.5 Medtronic Recent Developments/Updates
6.4 Ambu A/S
6.4.1 Ambu A/S Company Information
6.4.2 Ambu A/S Description and Business Overview
6.4.3 Ambu A/S Interventional Pulmonology Device Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Ambu A/S Interventional Pulmonology Device Product Portfolio
6.4.5 Ambu A/S Recent Developments/Updates
6.5 Pentax (HOYA)
6.5.1 Pentax (HOYA) Company Information
6.5.2 Pentax (HOYA) Description and Business Overview
6.5.3 Pentax (HOYA) Interventional Pulmonology Device Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Pentax (HOYA) Interventional Pulmonology Device Product Portfolio
6.5.5 Pentax (HOYA) Recent Developments/Updates
6.6 Micro Tech
6.6.1 Micro Tech Company Information
6.6.2 Micro Tech Description and Business Overview
6.6.3 Micro Tech Interventional Pulmonology Device Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Micro Tech Interventional Pulmonology Device Product Portfolio
6.6.5 Micro Tech Recent Developments/Updates
6.7 Fujifilm
6.7.1 Fujifilm Company Information
6.7.2 Fujifilm Description and Business Overview
6.7.3 Fujifilm Interventional Pulmonology Device Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Fujifilm Interventional Pulmonology Device Product Portfolio
6.7.5 Fujifilm Recent Developments/Updates
6.8 CONMED
6.8.1 CONMED Company Information
6.8.2 CONMED Description and Business Overview
6.8.3 CONMED Interventional Pulmonology Device Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 CONMED Interventional Pulmonology Device Product Portfolio
6.8.5 CONMED Recent Developments/Updates
6.9 Teleflex Medical
6.9.1 Teleflex Medical Company Information
6.9.2 Teleflex Medical Description and Business Overview
6.9.3 Teleflex Medical Interventional Pulmonology Device Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Teleflex Medical Interventional Pulmonology Device Product Portfolio
6.9.5 Teleflex Medical Recent Developments/Updates
6.10 ICU Medical
6.10.1 ICU Medical Company Information
6.10.2 ICU Medical Description and Business Overview
6.10.3 ICU Medical Interventional Pulmonology Device Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 ICU Medical Interventional Pulmonology Device Product Portfolio
6.10.5 ICU Medical Recent Developments/Updates
6.11 Medi-Globe
6.11.1 Medi-Globe Company Information
6.11.2 Medi-Globe Description and Business Overview
6.11.3 Medi-Globe Interventional Pulmonology Device Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Medi-Globe Interventional Pulmonology Device Product Portfolio
6.11.5 Medi-Globe Recent Developments/Updates
6.12 Merit Medical Systems
6.12.1 Merit Medical Systems Company Information
6.12.2 Merit Medical Systems Description and Business Overview
6.12.3 Merit Medical Systems Interventional Pulmonology Device Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Merit Medical Systems Interventional Pulmonology Device Product Portfolio
6.12.5 Merit Medical Systems Recent Developments/Updates
6.13 TRACOE medical
6.13.1 TRACOE medical Company Information
6.13.2 TRACOE medical Description and Business Overview
6.13.3 TRACOE medical Interventional Pulmonology Device Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 TRACOE medical Interventional Pulmonology Device Product Portfolio
6.13.5 TRACOE medical Recent Developments/Updates
6.14 Karl Storz
6.14.1 Karl Storz Company Information
6.14.2 Karl Storz Description and Business Overview
6.14.3 Karl Storz Interventional Pulmonology Device Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Karl Storz Interventional Pulmonology Device Product Portfolio
6.14.5 Karl Storz Recent Developments/Updates
6.15 Verathon
6.15.1 Verathon Company Information
6.15.2 Verathon Description and Business Overview
6.15.3 Verathon Interventional Pulmonology Device Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Verathon Interventional Pulmonology Device Product Portfolio
6.15.5 Verathon Recent Developments/Updates
6.16 Well Lead
6.16.1 Well Lead Company Information
6.16.2 Well Lead Description and Business Overview
6.16.3 Well Lead Interventional Pulmonology Device Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Well Lead Interventional Pulmonology Device Product Portfolio
6.16.5 Well Lead Recent Developments/Updates
6.17 TuoRen
6.17.1 TuoRen Company Information
6.17.2 TuoRen Description and Business Overview
6.17.3 TuoRen Interventional Pulmonology Device Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 TuoRen Interventional Pulmonology Device Product Portfolio
6.17.5 TuoRen Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Interventional Pulmonology Device Industry Chain Analysis
7.2 Interventional Pulmonology Device Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Interventional Pulmonology Device Production Mode & Process Analysis
7.4 Interventional Pulmonology Device Sales and Marketing
7.4.1 Interventional Pulmonology Device Sales Channels
7.4.2 Interventional Pulmonology Device Distributors
7.5 Interventional Pulmonology Device Customer Analysis
8 Interventional Pulmonology Device Market Dynamics
8.1 Interventional Pulmonology Device Industry Trends
8.2 Interventional Pulmonology Device Market Drivers
8.3 Interventional Pulmonology Device Market Challenges
8.4 Interventional Pulmonology Device Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Interventional Pulmonology Device Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Interventional Pulmonology Device Market Value by Surgical Type (US$ Million), 2025 vs 2032
Table 3. Global Interventional Pulmonology Device Market Value by Patient Type (US$ Million), 2025 vs 2032
Table 4. Global Interventional Pulmonology Device Market Value by Application (US$ Million), 2025 vs 2032
Table 5. Global Interventional Pulmonology Device Market Competitive Situation by Manufacturers in 2025
Table 6. Global Interventional Pulmonology Device Sales (K Units) of Key Manufacturers (2021–2026)
Table 7. Global Interventional Pulmonology Device Sales Market Share by Manufacturers (2021–2026)
Table 8. Global Interventional Pulmonology Device Revenue (US$ Million) by Manufacturers (2021–2026)
Table 9. Global Interventional Pulmonology Device Revenue Share by Manufacturers (2021–2026)
Table 10. Global Market Interventional Pulmonology Device Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 11. Global Key Players of Interventional Pulmonology Device, Industry Ranking, 2023 vs 2024 vs 2025
Table 12. Global Key Manufacturers of Interventional Pulmonology Device, Manufacturing Sites and Headquarters
Table 13. Global Key Manufacturers of Interventional Pulmonology Device, Product Types and Applications
Table 14. Global Key Manufacturers of Interventional Pulmonology Device, Date of Entry into the Industry
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Interventional Pulmonology Device Companies by Tier (Tier 1, Tier 2, Tier 3), based on Interventional Pulmonology Device Revenue, 2025
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 18. Global Interventional Pulmonology Device Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 19. Global Interventional Pulmonology Device Sales by Region (K Units), 2021–2026
Table 20. Global Interventional Pulmonology Device Sales Market Share by Region (2021–2026)
Table 21. Global Interventional Pulmonology Device Sales by Region (K Units), 2027–2032
Table 22. Global Interventional Pulmonology Device Sales Market Share by Region (2027–2032)
Table 23. Global Interventional Pulmonology Device Revenue by Region (US$ Million), 2021–2026
Table 24. Global Interventional Pulmonology Device Revenue Market Share by Region (2021–2026)
Table 25. Global Interventional Pulmonology Device Revenue by Region (US$ Million), 2027–2032
Table 26. Global Interventional Pulmonology Device Revenue Market Share by Region (2027–2032)
Table 27. North America Interventional Pulmonology Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 28. North America Interventional Pulmonology Device Sales by Country (K Units), 2021–2026
Table 29. North America Interventional Pulmonology Device Sales by Country (K Units), 2027–2032
Table 30. North America Interventional Pulmonology Device Revenue by Country (US$ Million), 2021–2026
Table 31. North America Interventional Pulmonology Device Revenue by Country (US$ Million), 2027–2032
Table 32. Europe Interventional Pulmonology Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 33. Europe Interventional Pulmonology Device Sales by Country (K Units), 2021–2026
Table 34. Europe Interventional Pulmonology Device Sales by Country (K Units), 2027–2032
Table 35. Europe Interventional Pulmonology Device Revenue by Country (US$ Million), 2021–2026
Table 36. Europe Interventional Pulmonology Device Revenue by Country (US$ Million), 2027–2032
Table 37. Asia Pacific Interventional Pulmonology Device Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 38. Asia Pacific Interventional Pulmonology Device Sales by Region (K Units), 2021–2026
Table 39. Asia Pacific Interventional Pulmonology Device Sales by Region (K Units), 2027–2032
Table 40. Asia Pacific Interventional Pulmonology Device Revenue by Region (US$ Million), 2021–2026
Table 41. Asia Pacific Interventional Pulmonology Device Revenue by Region (US$ Million), 2027–2032
Table 42. Latin America Interventional Pulmonology Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 43. Latin America Interventional Pulmonology Device Sales by Country (K Units), 2021–2026
Table 44. Latin America Interventional Pulmonology Device Sales by Country (K Units), 2027–2032
Table 45. Latin America Interventional Pulmonology Device Revenue by Country (US$ Million), 2021–2026
Table 46. Latin America Interventional Pulmonology Device Revenue by Country (US$ Million), 2027–2032
Table 47. Middle East and Africa Interventional Pulmonology Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 48. Middle East and Africa Interventional Pulmonology Device Sales by Country (K Units), 2021–2026
Table 49. Middle East and Africa Interventional Pulmonology Device Sales by Country (K Units), 2027–2032
Table 50. Middle East and Africa Interventional Pulmonology Device Revenue by Country (US$ Million), 2021–2026
Table 51. Middle East and Africa Interventional Pulmonology Device Revenue by Country (US$ Million), 2027–2032
Table 52. Global Interventional Pulmonology Device Sales (K Units) by Type (2021–2026)
Table 53. Global Interventional Pulmonology Device Sales (K Units) by Type (2027–2032)
Table 54. Global Interventional Pulmonology Device Sales Market Share by Type (2021–2026)
Table 55. Global Interventional Pulmonology Device Sales Market Share by Type (2027–2032)
Table 56. Global Interventional Pulmonology Device Revenue (US$ Million) by Type (2021–2026)
Table 57. Global Interventional Pulmonology Device Revenue (US$ Million) by Type (2027–2032)
Table 58. Global Interventional Pulmonology Device Revenue Market Share by Type (2021–2026)
Table 59. Global Interventional Pulmonology Device Revenue Market Share by Type (2027–2032)
Table 60. Global Interventional Pulmonology Device Price (US$/Unit) by Type (2021–2026)
Table 61. Global Interventional Pulmonology Device Price (US$/Unit) by Type (2027–2032)
Table 62. Global Interventional Pulmonology Device Sales (K Units) by Application (2021–2026)
Table 63. Global Interventional Pulmonology Device Sales (K Units) by Application (2027–2032)
Table 64. Global Interventional Pulmonology Device Sales Market Share by Application (2021–2026)
Table 65. Global Interventional Pulmonology Device Sales Market Share by Application (2027–2032)
Table 66. Global Interventional Pulmonology Device Revenue (US$ Million) by Application (2021–2026)
Table 67. Global Interventional Pulmonology Device Revenue (US$ Million) by Application (2027–2032)
Table 68. Global Interventional Pulmonology Device Revenue Market Share by Application (2021–2026)
Table 69. Global Interventional Pulmonology Device Revenue Market Share by Application (2027–2032)
Table 70. Global Interventional Pulmonology Device Price (US$/Unit) by Application (2021–2026)
Table 71. Global Interventional Pulmonology Device Price (US$/Unit) by Application (2027–2032)
Table 72. Boston Scientific Company Information
Table 73. Boston Scientific Description and Business Overview
Table 74. Boston Scientific Interventional Pulmonology Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 75. Boston Scientific Interventional Pulmonology Device Product
Table 76. Boston Scientific Recent Developments/Updates
Table 77. Olympus Company Information
Table 78. Olympus Description and Business Overview
Table 79. Olympus Interventional Pulmonology Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 80. Olympus Interventional Pulmonology Device Product
Table 81. Olympus Recent Developments/Updates
Table 82. Medtronic Company Information
Table 83. Medtronic Description and Business Overview
Table 84. Medtronic Interventional Pulmonology Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 85. Medtronic Interventional Pulmonology Device Product
Table 86. Medtronic Recent Developments/Updates
Table 87. Ambu A/S Company Information
Table 88. Ambu A/S Description and Business Overview
Table 89. Ambu A/S Interventional Pulmonology Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 90. Ambu A/S Interventional Pulmonology Device Product
Table 91. Ambu A/S Recent Developments/Updates
Table 92. Pentax (HOYA) Company Information
Table 93. Pentax (HOYA) Description and Business Overview
Table 94. Pentax (HOYA) Interventional Pulmonology Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 95. Pentax (HOYA) Interventional Pulmonology Device Product
Table 96. Pentax (HOYA) Recent Developments/Updates
Table 97. Micro Tech Company Information
Table 98. Micro Tech Description and Business Overview
Table 99. Micro Tech Interventional Pulmonology Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 100. Micro Tech Interventional Pulmonology Device Product
Table 101. Micro Tech Recent Developments/Updates
Table 102. Fujifilm Company Information
Table 103. Fujifilm Description and Business Overview
Table 104. Fujifilm Interventional Pulmonology Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 105. Fujifilm Interventional Pulmonology Device Product
Table 106. Fujifilm Recent Developments/Updates
Table 107. CONMED Company Information
Table 108. CONMED Description and Business Overview
Table 109. CONMED Interventional Pulmonology Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 110. CONMED Interventional Pulmonology Device Product
Table 111. CONMED Recent Developments/Updates
Table 112. Teleflex Medical Company Information
Table 113. Teleflex Medical Description and Business Overview
Table 114. Teleflex Medical Interventional Pulmonology Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 115. Teleflex Medical Interventional Pulmonology Device Product
Table 116. Teleflex Medical Recent Developments/Updates
Table 117. ICU Medical Company Information
Table 118. ICU Medical Description and Business Overview
Table 119. ICU Medical Interventional Pulmonology Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 120. ICU Medical Interventional Pulmonology Device Product
Table 121. ICU Medical Recent Developments/Updates
Table 122. Medi-Globe Company Information
Table 123. Medi-Globe Description and Business Overview
Table 124. Medi-Globe Interventional Pulmonology Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 125. Medi-Globe Interventional Pulmonology Device Product
Table 126. Medi-Globe Recent Developments/Updates
Table 127. Merit Medical Systems Company Information
Table 128. Merit Medical Systems Description and Business Overview
Table 129. Merit Medical Systems Interventional Pulmonology Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 130. Merit Medical Systems Interventional Pulmonology Device Product
Table 131. Merit Medical Systems Recent Developments/Updates
Table 132. TRACOE medical Company Information
Table 133. TRACOE medical Description and Business Overview
Table 134. TRACOE medical Interventional Pulmonology Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 135. TRACOE medical Interventional Pulmonology Device Product
Table 136. TRACOE medical Recent Developments/Updates
Table 137. Karl Storz Company Information
Table 138. Karl Storz Description and Business Overview
Table 139. Karl Storz Interventional Pulmonology Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 140. Karl Storz Interventional Pulmonology Device Product
Table 141. Karl Storz Recent Developments/Updates
Table 142. Verathon Company Information
Table 143. Verathon Description and Business Overview
Table 144. Verathon Interventional Pulmonology Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 145. Verathon Interventional Pulmonology Device Product
Table 146. Verathon Recent Developments/Updates
Table 147. Well Lead Company Information
Table 148. Well Lead Description and Business Overview
Table 149. Well Lead Interventional Pulmonology Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 150. Well Lead Interventional Pulmonology Device Product
Table 151. Well Lead Recent Developments/Updates
Table 152. TuoRen Company Information
Table 153. TuoRen Description and Business Overview
Table 154. TuoRen Interventional Pulmonology Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 155. TuoRen Interventional Pulmonology Device Product
Table 156. TuoRen Recent Developments/Updates
Table 157. Key Raw Materials Lists
Table 158. Raw Materials Key Suppliers Lists
Table 159. Interventional Pulmonology Device Distributors List
Table 160. Interventional Pulmonology Device Customers List
Table 161. Interventional Pulmonology Device Market Trends
Table 162. Interventional Pulmonology Device Market Drivers
Table 163. Interventional Pulmonology Device Market Challenges
Table 164. Interventional Pulmonology Device Market Restraints
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
Table 168. Authors List of This Report
List of Figures
Figure 1. Product Picture of Interventional Pulmonology Device
Figure 2. Global Interventional Pulmonology Device Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Interventional Pulmonology Device Market Share by Type: 2025 & 2032
Figure 4. Bronchoscope Product Picture
Figure 5. Pleuroscopy Product Picture
Figure 6. Respiratory Endotherapy Devices Product Picture
Figure 7. IP Therapeutic Device Product Picture
Figure 8. Tracheostomy Tube Product Picture
Figure 9. Global Interventional Pulmonology Device Market Value by Surgical Type (US$ Million), 2021–2032
Figure 10. Global Interventional Pulmonology Device Market Share by Surgical Type: 2025 vs 2032
Figure 11. Minimally Invasive Procedures Product Picture
Figure 12. Surgical Therapy Product Picture
Figure 13. Other Product Picture
Figure 14. Global Interventional Pulmonology Device Market Value by Patient Type (US$ Million), 2021–2032
Figure 15. Global Interventional Pulmonology Device Market Share by Patient Type: 2025 vs 2032
Figure 16. Adult Patients Product Picture
Figure 17. Geriatric Patients Product Picture
Figure 18. Pediatric Patients Product Picture
Figure 19. Global Interventional Pulmonology Device Market Value by Application (US$ Million), 2021–2032
Figure 20. Global Interventional Pulmonology Device Market Share by Application: 2025 & 2032
Figure 21. Hospital and Clinic
Figure 22. Ambulatory Surgical Centers
Figure 23. Global Interventional Pulmonology Device Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 24. Global Interventional Pulmonology Device Market Size (US$ Million), 2021–2032
Figure 25. Global Interventional Pulmonology Device Sales (K Units), 2021–2032
Figure 26. Global Interventional Pulmonology Device Average Price (US$/Unit), 2021–2032
Figure 27. Interventional Pulmonology Device Report Years Considered
Figure 28. Interventional Pulmonology Device Sales Share by Manufacturers in 2025
Figure 29. Global Interventional Pulmonology Device Revenue Share by Manufacturers in 2025
Figure 30. Top 5 and Top 10 Global Interventional Pulmonology Device Players: Market Share by Revenue in Interventional Pulmonology Device in 2025
Figure 31. Interventional Pulmonology Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 32. Global Interventional Pulmonology Device Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 33. North America Interventional Pulmonology Device Sales Market Share by Country (2021–2032)
Figure 34. North America Interventional Pulmonology Device Revenue Market Share by Country (2021–2032)
Figure 35. United States Interventional Pulmonology Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Canada Interventional Pulmonology Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Europe Interventional Pulmonology Device Sales Market Share by Country (2021–2032)
Figure 38. Europe Interventional Pulmonology Device Revenue Market Share by Country (2021–2032)
Figure 39. Germany Interventional Pulmonology Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. France Interventional Pulmonology Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. U.K. Interventional Pulmonology Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Italy Interventional Pulmonology Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Russia Interventional Pulmonology Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Asia Pacific Interventional Pulmonology Device Sales Market Share by Region (2021–2032)
Figure 45. Asia Pacific Interventional Pulmonology Device Revenue Market Share by Region (2021–2032)
Figure 46. China Interventional Pulmonology Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Japan Interventional Pulmonology Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. South Korea Interventional Pulmonology Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. India Interventional Pulmonology Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Australia Interventional Pulmonology Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. China Taiwan Interventional Pulmonology Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Southeast Asia Interventional Pulmonology Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Latin America Interventional Pulmonology Device Sales Market Share by Country (2021–2032)
Figure 54. Latin America Interventional Pulmonology Device Revenue Market Share by Country (2021–2032)
Figure 55. Mexico Interventional Pulmonology Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 56. Brazil Interventional Pulmonology Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 57. Argentina Interventional Pulmonology Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 58. Middle East and Africa Interventional Pulmonology Device Sales Market Share by Country (2021–2032)
Figure 59. Middle East and Africa Interventional Pulmonology Device Revenue Market Share by Country (2021–2032)
Figure 60. Turkey Interventional Pulmonology Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 61. Saudi Arabia Interventional Pulmonology Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 62. UAE Interventional Pulmonology Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 63. Global Sales Market Share of Interventional Pulmonology Device by Type (2021–2032)
Figure 64. Global Revenue Market Share of Interventional Pulmonology Device by Type (2021–2032)
Figure 65. Global Interventional Pulmonology Device Price (US$/Unit) by Type (2021–2032)
Figure 66. Global Sales Market Share of Interventional Pulmonology Device by Application (2021–2032)
Figure 67. Global Revenue Market Share of Interventional Pulmonology Device by Application (2021–2032)
Figure 68. Global Interventional Pulmonology Device Price (US$/Unit) by Application (2021–2032)
Figure 69. Interventional Pulmonology Device Value Chain
Figure 70. Channels of Distribution (Direct Vs Distribution)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
